2026 FDA Insurance 
The Checkup by Singlecare
AUGUST 1, 2024
It is an antidepressant approved by the Food and Drug Administration (FDA) to treat major depressive disorder in adults. With or without insurance or Medicare, there are additional ways to reduce out-of-pocket expenses for Trintellix. You can contact your insurance provider to see if Trintellix is included in your plan’s formulary.
The Checkup by Singlecare
DECEMBER 29, 2022
Is Fycompa covered by insurance? | How much does Fycompa cost without insurance? | How to get Fycompa without insurance. Since Fycompa is only sold as a brand-name drug, people without insurance may find that it might not be the best economical choice. Is Fycompa covered by insurance? SingleCare price.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
AUGUST 23, 2023
Is Janumet covered by insurance? | How much does Janumet cost without insurance? | How to get Janumet without insurance Janumet is a brand-name prescription drug that combines two diabetes medications: metformin and sitagliptin. A generic version of sitagliptin may be available as early as 2026 or as late as 2029.
The Checkup by Singlecare
AUGUST 20, 2024
It is approved by the Food and Drug Administration (FDA) to help manage blood sugar levels in individuals with diabetes mellitus. Without insurance, the cost of Fiasp Flextouch for five pens can be over $700. Without insurance, the cost of Fiasp Flextouch for five pens can be over $700. Is Fiasp Flextouch covered by insurance?
Pharmaceutical Technology
JUNE 19, 2025
By GlobalData Learn more about Strategic Intelligence The company then plans to expand into a Phase Ib proof-of-concept trial in patients with KCNT1-related epilepsy in early 2026. The US Food and Drug Administration (FDA) has awarded ABS-1230 both orphan drug and rare paediatric designations.
The Checkup by Singlecare
FEBRUARY 10, 2025
Food and Drug Administration (FDA) approved Januvia in 2006. No generic version of Januvia is available in the United States, but this could change in 2026 when the main patent expires. The first patent, covering the dihydrogen phosphate salt of sitagliptin, expires on November 24, 2026.
PharmaShots
FEBRUARY 22, 2023
A qualifying medication is prescribed by their healthcare provider The patients who have no insurance or have Medicare Part D Patients who are not enrolled in Medicaid, full Low-Income Subsidy, or Veterans (VA) benefits. The patient must-have commercial health insurance to use the savings card. Virgin Islands.
Expert insights. Personalized for you.
98 
Let's personalize your content